Matching trials
2,411 results
- PK and ECG Determinations Following 8 Weeks of HyBryte Treatment for Cutaneous T-Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of PK and ECG Determinations Following 8 Weeks of HyBryte Treatment for Cutaneous T-Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- PK Profile and Preliminary Efficacy of TNP-2092 Capsules in Liver Cirrhosis Patients With Hyperammonemia: Complete Statistical AnalysisIndependent statistical analysis of PK Profile and Preliminary Efficacy of TNP-2092 Capsules in Liver Cirrhosis Patients With Hyperammonemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- PLANE-PCIndependent statistical analysis of Pembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04848337).
- PLANET 1Independent statistical analysis of Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Planned Donor Lymphocyte Infusion (DLI) After Allogeneic Stem Cell Transplantation (SCT): Complete Statistical AnalysisIndependent statistical analysis of Planned Donor Lymphocyte Infusion (DLI) After Allogeneic Stem Cell Transplantation (SCT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Plasma Therapy of COVID-19 in Severely Ill Patients: Complete Statistical AnalysisIndependent statistical analysis of Plasma Therapy of COVID-19 in Severely Ill Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04359810).
- Platinum-Based Chemotherapy Plus Ramucirumab in Patients With Advanced NSCLC Who Have Progressed on First Line Anti-PD-1 Immunotherapy: Complete Statistical AnalysisIndependent statistical analysis of Platinum-Based Chemotherapy Plus Ramucirumab in Patients With Advanced NSCLC Who Have Progressed on First Line Anti-PD-1 Immunotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Plerixafor and Cemiplimab in Metastatic Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Plerixafor and Cemiplimab in Metastatic Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04177810).
- Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate: Complete Statistical AnalysisIndependent statistical analysis of Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00165503).
- Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 2: Complete Statistical AnalysisIndependent statistical analysis of Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- PLX038 (PEGylated SN38) and Rucaparib in Solid Tumors and Small Cell Cancers: Complete Statistical AnalysisIndependent statistical analysis of PLX038 (PEGylated SN38) and Rucaparib in Solid Tumors and Small Cell Cancers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PLX2853 as a Single Agent in Advanced Gynecological Malignancies and in Combination With Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer: Complete Statistical AnalysisIndependent statistical analysis of PLX2853 as a Single Agent in Advanced Gynecological Malignancies and in Combination With Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…
- PMOD03Independent statistical analysis of Dysport in Post-Surgical Neuralgia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03663101).
- PMS-001Independent statistical analysis of An Open-Label Study of Oral NNZ-2591 in Phelan-McDermid Syndrome (PMS-001): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05025241).
- POC1Independent statistical analysis of Evaluation of Doxycycline Verses Placebo for the Treatment of Severe Nonproliferative or Mild or Moderate Proliferative Diabetic Retinopathy: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- POD1UM-201Independent statistical analysis of the phase 2 POD1UM-201 study of retifanlimab in metastatic Merkel cell carcinoma, including trial design, objective response rate, statistical methodology, safety, interpretation, and limitations.
- PODOIndependent statistical analysis of A Study to Evaluate PF-06730512 in Adults With Focal Segmental Glomerulosclerosis (FSGS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- POINTIndependent statistical analysis of Pediatric Oncology Nutrition Intervention Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06175273).
- POLLYIndependent statistical analysis of ER Reactivation Therapy for Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02188745).
- Poly-ICLCIndependent statistical analysis of Enhancement by Poly-ICLC During HIV-1 Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02071095).
- PolypillIndependent statistical analysis of Phase II Study of Heart Polypill Safety and Efficacy in Primary Prevention of Cardiovascular Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Pomalidomide for Chronic Graft-versus-Host Disease: Complete Statistical AnalysisIndependent statistical analysis of Pomalidomide for Chronic Graft-versus-Host Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01688466).
- Ponatinib for Patients Whose Advanced Solid Tumor Cancer Has Activating Mutations Involving the Following Genes: FGFR1, FGFR2, FGFR3, FGFR4, RET, KIT.: Complete Statistical AnalysisIndependent statistical analysis of Ponatinib for Patients Whose Advanced Solid Tumor Cancer Has Activating Mutations Involving the Following Genes: FGFR1, FGFR2, FGFR3, FGFR4, RET, KIT.: primary endpoint results, effect estimate with confidence…
- Ponatinib Hydrochloride in Treating Patients With Advanced Biliary Cancer With FGFR2 Fusions: Complete Statistical AnalysisIndependent statistical analysis of Ponatinib Hydrochloride in Treating Patients With Advanced Biliary Cancer With FGFR2 Fusions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- POPLARIndependent statistical analysis of the randomized phase 2 POPLAR trial evaluating imsidolimab versus placebo in adults with palmoplantar pustulosis, including PPPASI, response endpoints, MMRM, logistic regression, confidence intervals, and safety.
- Portion Control Treatment for Obesity: Complete Statistical AnalysisIndependent statistical analysis of Portion Control Treatment for Obesity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01451554).
- POST-OP PilotIndependent statistical analysis of Pilot Study of Atorvastatin for Orthopedic Surgery Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02197065).
- Post-operative Radiation With Cetuximab for Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck: Complete Statistical AnalysisIndependent statistical analysis of Post-operative Radiation With Cetuximab for Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Post-stroke Neural Plasticity With Atomoxetine: Complete Statistical AnalysisIndependent statistical analysis of Post-stroke Neural Plasticity With Atomoxetine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02788357).
- Post-Transplant Bortezomib and High Dose Cyclophosphamide as Graft-Versus-Host Disease (GVHD) Prophylaxis: Complete Statistical AnalysisIndependent statistical analysis of Post-Transplant Bortezomib and High Dose Cyclophosphamide as Graft-Versus-Host Disease (GVHD) Prophylaxis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Postoperative Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Postoperative Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Poststroke Depression in Hemorrhagic Stroke: Complete Statistical AnalysisIndependent statistical analysis of Poststroke Depression in Hemorrhagic Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03826875).
- POWERIndependent statistical analysis of Pre-Operative Window of Adjuvant Endocrine Therapy to Inform RT Decisions in Older Women With Early-Stage Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- POWER PIINCIndependent statistical analysis of Preoperative Window of Endocrine Therapy Provides Information to Increase Compliance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01614210).
- PPARγ Agonist Treatment for Cocaine Dependence: Complete Statistical AnalysisIndependent statistical analysis of PPARγ Agonist Treatment for Cocaine Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02774343).
- Prasugrel Versus Placebo in Adult Sickle Cell Disease: Complete Statistical AnalysisIndependent statistical analysis of Prasugrel Versus Placebo in Adult Sickle Cell Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01167023).
- Pre-op Rectal ChemoRad +/- Cetuximab: Complete Statistical AnalysisIndependent statistical analysis of Pre-op Rectal ChemoRad +/- Cetuximab: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00527111).
- Pre-operative Treatment for Patients With Untreated Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Pre-operative Treatment for Patients With Untreated Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03138720).
- PrE0801Independent statistical analysis of NEXT: Subsequent Exposure to Tyrosine Kinase Inhibition at Recurrence After Adjuvant Therapy in Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- PrE1003Independent statistical analysis of Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- PrefHERIndependent statistical analysis of Participant Preference of Subcutaneous (SC) Versus Intravenous (IV) Herceptin (Trastuzumab) in Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer: primary endpoint results, effect estimate with confidence…
- Prefrontal Cortex Stimulation as Treatment for Crack-cocaine Addiction: Complete Statistical AnalysisIndependent statistical analysis of Prefrontal Cortex Stimulation as Treatment for Crack-cocaine Addiction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01337297).
- Pregabalin for the Treatment of Vulvodynia: Complete Statistical AnalysisIndependent statistical analysis of Pregabalin for the Treatment of Vulvodynia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00853229).
- Pregabalin in Preventing Acute Pain Syndrome in Patients Receiving Paclitaxel: Complete Statistical AnalysisIndependent statistical analysis of Pregabalin in Preventing Acute Pain Syndrome in Patients Receiving Paclitaxel: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01637077).
- Preliminary Efficacy, Safety and Pharmacokinetics Study of Nepadutant in Infant With Feeding Intolerance: Complete Statistical AnalysisIndependent statistical analysis of Preliminary Efficacy, Safety and Pharmacokinetics Study of Nepadutant in Infant With Feeding Intolerance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Preoperative Fulvestrant With or Without Enzalutamide in ER+/Her2- Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Preoperative Fulvestrant With or Without Enzalutamide in ER+/Her2- Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02955394).
- Preoperative Pemetrexed and Carboplatin for Select Stage IB, II, and III Non-Squamous Non-Small-Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Preoperative Pemetrexed and Carboplatin for Select Stage IB, II, and III Non-Squamous Non-Small-Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Preoperative Thalidomide With Radiation Therapy For Patients With Low-Grade Primary Soft Tissue Sarcoma or Thalidomide With Radiation Therapy and Chemotherapy For Patients With High-Grade or Intermediate-Grade Primary Soft Tissue Sarcoma of the Arm, Leg, or Body Wall: Complete Statistical AnalysisIndependent statistical analysis of Preoperative Thalidomide With Radiation Therapy For Patients With Low-Grade Primary Soft Tissue Sarcoma or Thalidomide With Radiation Therapy and Chemotherapy For Patients With High-Grade or Intermediate-Grade Primary Soft…
- Preoperative Treatment of Breast Cancer With Two Different Sequential Treatment Regimens: Complete Statistical AnalysisIndependent statistical analysis of Preoperative Treatment of Breast Cancer With Two Different Sequential Treatment Regimens: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Preoperative Treatment With Cetuximab and/or IMC-A12: Complete Statistical AnalysisIndependent statistical analysis of Preoperative Treatment With Cetuximab and/or IMC-A12: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00957853).